Diagnostic Autonomic denied as not medically necessary by Cigna?

Cigna's specific coverage criteria for diagnostic autonomic are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied Autonomic Diagnostic Testing as Not Medically Necessary

Autonomic nervous system testing — which may include tilt-table evaluation, quantitative sudomotor axon reflex testing (QSART), thermoregulatory sweat testing, and cardiovascular autonomic reflex studies — is frequently denied by Cigna on medical-necessity grounds when the clinical documentation does not clearly establish that the testing is required to diagnose or manage a condition that cannot be adequately evaluated by less intensive means. Cigna applies its own Medical Policy criteria for autonomic function testing; the denial letter should identify the specific guideline number. Retrieve that policy directly from Cigna's website or by calling the provider line, because the exact criteria change and the version in effect on the date of service is what governs.

## Why This Denial Is Appealable

Autonomic disorders — including dysautonomia, postural orthostatic tachycardia syndrome (POTS), small-fiber neuropathy, and diabetic autonomic neuropathy — produce symptoms (lightheadedness, syncope, anhidrosis, exercise intolerance) that cannot always be confirmed or differentiated without objective autonomic testing. If your physician ordered testing because clinical evaluation alone was insufficient to guide treatment, that clinical reasoning is the foundation of a strong appeal.

## Federal Appeal Framework

Under ACA Section 2719 and its implementing regulations, non-grandfathered plans must provide internal appeal and external review rights. Under ERISA Section 503, self-funded plans must provide a full-and-fair review. You typically have 180 days from the denial notice to file an internal appeal. If the internal appeal is upheld, you may request an independent external review — generally within four months of the final internal denial. For urgent situations (acute diagnostic need), request an expedited external review, which must be decided within 72 hours.

## Documentation to Gather

• Diagnosis confirmation: Chart notes documenting symptoms, duration, and severity; specialist evaluation if applicable.
• Prior workup history: Records showing which evaluations were already performed and why they were insufficient to establish a diagnosis or guide therapy.
• Clinical severity: Functional impact statements, fall risk documentation, medication adjustments already attempted.
• Ordering physician letter: A detailed medical-necessity letter explaining why autonomic testing is required for this patient at this time, referencing the applicable professional society guideline (e.g., the relevant American Autonomic Society or American Academy of Neurology guideline) without asserting specific numeric thresholds — instead citing the patient's specific chart findings.
• Specialist support: If a neurologist or cardiologist ordered or supported the study, include their notes.

## Criteria-Mapping Structure

Obtain Cigna's published coverage policy for autonomic testing and your prescriber's letter. Create a two-column table:

| Cigna Policy Requirement | How Your Chart Satisfies It | |---|---| | [Copy each requirement verbatim from the policy] | [Cite the specific chart date, note, or result that satisfies it] |

This structure forces the reviewer to address each element individually rather than issuing a blanket denial, and it becomes the evidentiary record if the case proceeds to external review.